Lamivudine: A new strategy to suppress HBV replication in the pretransplant setting

Transplantation Proceedings

Volumn 32, Issue 8, 2000, Pages 2642-

  Macedo, G ^a,b   Maia, J C ^a   Gomes, A ^a   Beleza, M ^a   Teixeira, A ^a   Ribeiro, A ^a  

^a Gastroenterology and Liver Transplant Units   (Portugal)

^b NONE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; LAMIVUDINE; TRIACYLGLYCEROL LIPASE; VIRUS DNA;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; PREOPERATIVE CARE; PRIORITY JOURNAL; VIRUS INHIBITION;

ADULT; ANTIVIRAL AGENTS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER TRANSPLANTATION; MIDDLE AGED; PREMEDICATION; RECURRENCE; VIRUS REPLICATION;

EID: 0034533622     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01817-0     Document Type: Conference Paper

References (3)

1. Samuel D, Muller R, Alexander G: N Engl J Med 329:1842, 1993
2. Mora MP, Klintmalm GP, Poplauski SS: Transplant Proc 2:1549, 1990
3. Grellier L, Mutimer D, Ahmed M: Lancet 348:1212, 1996